Clonality and Evolutionary History of Rhabdomyosarcoma

PLoS Genetics

Volumn 11, Issue 3, 2015, Pages

  Chen, Li ^a   Shern, Jack F ^a   Wei, Jun S ^a   Yohe, Marielle E ^a   Song, Young K ^a   Hurd, Laura ^a   Liao, Hongling ^a   Catchpoole, Daniel ^b   Skapek, Stephen X ^c   Barr, Frederic G ^a   Hawkins, Douglas S ^d   Khan, Javed ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 4; ONCOPROTEIN; PAIRED BOX TRANSCRIPTION FACTOR; PAX3-FOXO1A FUSION PROTEIN, HUMAN;

ALLELIC IMBALANCE; ANIMAL CELL; ARTICLE; CCDN1 GENE; CHILD; CHROMOSOME 11P; CLONAL VARIATION; CONTROLLED STUDY; COPY NUMBER VARIATION; CUL2 GENE; FGFR4 GENE; GENE; GENE DUPLICATION; GENE FUSION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; PAX3 FOXO1 FUSION GENE; PKN1 GENE; POINT MUTATION; RHABDOMYOSARCOMA; SOMATIC MUTATION; TETRAPLOIDY; TTK GENE; WHOLE GENOME SEQUENCING; ADOLESCENT; CHROMOSOME 11; DNA SEQUENCE; GENETIC ASSOCIATION; GENETICS; HUMAN GENOME; INFANT; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 11; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; LOSS OF HETEROZYGOSITY; ONCOGENE PROTEINS, FUSION; PAIRED BOX TRANSCRIPTION FACTORS; RHABDOMYOSARCOMA; SEQUENCE ANALYSIS, DNA;

EID: 84926138661     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1005075     Document Type: Article

References (63)

1. Yates LR, Campbell PJ, (2012) Evolution of the cancer genome. Nat Rev Genet 13: 795–806. doi: 10.1038/nrg3317 23044827
2. Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, et al. (2012) The life history of 21 breast cancers. Cell 149: 994–1007. doi: 10.1016/j.cell.2012.04.023 22608083
3. Tomasetti C, Vogelstein B, Parmigiani G, (2013) Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation. Proc Natl Acad Sci U S A 110: 1999–2004. doi: 10.1073/pnas.1221068110 23345422
4. Stratton MR, Campbell PJ, Futreal PA, (2009) The cancer genome. Nature 458: 719–724. doi: 10.1038/nature07943 19360079
5. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, et al. (2011) Initial genome sequencing and analysis of multiple myeloma. Nature 471: 467–472. doi: 10.1038/nature09837 21430775
6. Ding L, Ellis MJ, Li S, Larson DE, Chen K, et al. (2010) Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464: 999–1005. doi: 10.1038/nature08989 20393555
7. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, et al. (2010) DNMT3A mutations in acute myeloid leukemia. N Engl J Med 363: 2424–2433. doi: 10.1056/NEJMoa1005143 21067377
8. Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, et al. (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475: 101–105. doi: 10.1038/nature10113 21642962
9. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, et al. (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481: 506–510. doi: 10.1038/nature10738 22237025
10. Yachida S, Jones S, Bozic I, Antal T, Leary R, et al. (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114–1117. doi: 10.1038/nature09515 20981102
11. Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, et al. (2013) Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152: 714–726. doi: 10.1016/j.cell.2013.01.019 23415222
12. Shanafelt TD, Hanson C, Dewald GW, Witzig TE, LaPlant B, et al. (2008) Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression. J Clin Oncol 26: e5–6. doi: 10.1200/JCO.2008.16.7874 18467710
13. Shah SP, Roth A, Goya R, Oloumi A, Ha G, et al. (2012) The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486: 395–399. doi: 10.1038/nature10933 22495314
14. Durinck S, Ho C, Wang NJ, Liao W, Jakkula LR, et al. (2011) Temporal Dissection of Tumorigenesis in Primary Cancers. Cancer Discovery 1: 137–143. doi: 10.1158/2159-8290.CD-11-0028 21984974
15. Ognjanovic S, Linabery AM, Charbonneau B, Ross JA, (2009) Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975–2005. Cancer 115: 4218–4226. doi: 10.1002/cncr.24465 19536876
16. Malempati S, Hawkins DS, (2012) Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft-Tissue Sarcoma Committee experience and rationale for current COG studies. Pediatr Blood Cancer 59: 5–10. doi: 10.1002/pbc.24118 22378628
17. Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, et al. (2003) Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma—a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21: 78–84. 12506174
18. Linardic CM, (2008) PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett 270: 10–18. doi: 10.1016/j.canlet.2008.03.035 18457914
19. Scrable H, Cavenee W, Ghavimi F, Lovell M, Morgan K, et al. (1989) A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci U S A 86: 7480–7484. 2798419
20. Stratton MR, Fisher C, Gusterson BA, Cooper CS, (1989) Detection of point mutations in N-ras and K-ras genes of human embryonal rhabdomyosarcomas using oligonucleotide probes and the polymerase chain reaction. Cancer Research 49: 6324–6327. 2680062
21. Shukla N, Ameur N, Yilmaz I, Nafa K, Lau CY, et al. (2012) Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways. Clin Cancer Res 18: 748–757. doi: 10.1158/1078-0432.CCR-11-2056 22142829
22. Taylor JGt, Cheuk AT, Tsang PS, Chung JY, Song YK, et al. (2009) Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest 119: 3395–3407. doi: 10.1172/JCI39703 19809159
23. Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, et al. (2014) Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov 4: 216–231. doi: 10.1158/2159-8290.CD-13-0639 24436047
24. Chen X, Stewart E, Shelat AA, Qu C, Bahrami A, et al. (2013) Targeting oxidative stress in embryonal rhabdomyosarcoma. Cancer Cell 24: 710–724. doi: 10.1016/j.ccr.2013.11.002 24332040
25. Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, et al. (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31: 213–219. doi: 10.1038/nbt.2514 23396013
26. Stamatoyannopoulos JA, Adzhubei I, Thurman RE, Kryukov GV, Mirkin SM, et al. (2009) Human mutation rate associated with DNA replication timing. Nature Genetics 41: 393–395. doi: 10.1038/ng.363 19287383
27. Chen CL, Rappailles A, Duquenne L, Huvet M, Guilbaud G, et al. (2010) Impact of replication timing on non-CpG and CpG substitution rates in mammalian genomes. Genome Research 20: 447–457. doi: 10.1101/gr.098947.109 20103589
28. Xia SJ, Pressey JG, Barr FG, (2002) Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther 1: 97–104. 12170781
29. Barr FG, Nauta LE, Davis RJ, Schafer BW, Nycum LM, et al. (1996) In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Human Molecular Genetics 5: 15–21. 8789435
30. Mukai H, (2003) The structure and function of PKN, a protein kinase having a catalytic domain homologous to that of PKC. Journal of Biochemistry 133: 17–27. 12761194
31. James RG, Bosch KA, Kulikauskas RM, Yang PTT, Robin NC, et al. (2013) Protein Kinase PKN1 Represses Wnt/beta-Catenin Signaling in Human Melanoma Cells. Journal of Biological Chemistry 288: 34658–34670. doi: 10.1074/jbc.M113.500314 24114839
32. Marinissen MT, Chiariello M, Gutkind JS, (2001) Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes & Development 15: 535–553.
33. Kohsaka S, Shukla N, Ameur N, Ito T, Ng CKY, et al. (2014) A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations. Nature Genetics 46: 595–600. doi: 10.1038/ng.2969 24793135
34. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, et al. (2003) High frequency of BRAF mutations in nevi. Nature Genetics 33: 19–20. 12447372
35. Chan TL, Zhao W, Leung SY, Yuen ST, Project CG, (2003) BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Research 63: 4878–4881. 12941809
36. Mullighan CG, Phillips LA, Su X, Ma J, Miller CB, et al. (2008) Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322: 1377–1380. doi: 10.1126/science.1164266 19039135
37. Henry I, Bonaitipellie C, Chehensse V, Beldjord C, Schwartz C, et al. (1991) Uniparental Paternal Disomy in a Genetic Cancer-Predisposing Syndrome. Nature 351: 665–667. 1675767
38. KOUFOS A, HANSEN MF, LAMPKIN BC, WORKMAN ML, COPELAND NG, et al. (1984) Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour. Nature 309: 170–172. 6325936
39. Gripp KW, (2005) Tumor predisposition in Costello syndrome. American Journal of Medical Genetics Part C-Seminars in Medical Genetics 137C: 72–77. 16010679
40. Kratz CP, Rapisuwon S, Reed H, Hasle H, Rosenberg PS, (2011) Cancer in Noonan, Costello, Cardiofaciocutaneous and LEOPARD Syndromes. American Journal of Medical Genetics Part C-Seminars in Medical Genetics 157C: 83–89. doi: 10.1002/ajmg.c.30300 21500339
41. Sung L, Anderson JR, Arndt C, Raney B, Meyer WH, et al. (2004) Neurofibromatosis in children with rhabdomyosarcoma: A report from the intergroup Rhabdomyosarcoma Study IV. Journal of Pediatrics 144: 666–668. 15127010
42. DeBaun MR, Tucker MA, (1998) Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. Journal of Pediatrics 132: 398–400. 9544889
43. James RG, Bosch KA, Kulikauskas RM, Yang PT, Robin NC, et al. (2013) Protein kinase PKN1 represses Wnt/beta-catenin signaling in human melanoma cells. J Biol Chem 288: 34658–34670. doi: 10.1074/jbc.M113.500314 24114839
44. Dong LQ, Landa LR, Wick MJ, Zhu L, Mukai H, et al. (2000) Phosphorylation of protein kinase N by phosphoinositide-dependent protein kinase-1 mediates insulin signals to the actin cytoskeleton. Proc Natl Acad Sci U S A 97: 5089–5094. 10792047
45. Potthoff MJ, Olson EN, (2007) MEF2: a central regulator of diverse developmental programs. Development 134: 4131–4140. 17959722
46. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, et al. (2011) The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells. Cell 147: 759–772. doi: 10.1016/j.cell.2011.09.048 22078877
47. Tremblay AM, Missiaglia E, Galli GG, Hettmer S, Urcia R, et al. (2014) The Hippo Transducer YAP1 Transforms Activated Satellite Cells and Is a Potent Effector of Embryonal Rhabdomyosarcoma Formation. Cancer Cell 26: 273–287. doi: 10.1016/j.ccr.2014.05.029 25087979
48. Shao DD, Xue W, Krall EB, Bhutkar A, Piccioni F, et al. (2014) KRAS and YAP1 Converge to Regulate EMT and Tumor Survival. Cell 158: 171–184. doi: 10.1016/j.cell.2014.06.004 24954536
49. Kapoor A, Yao WT, Ying HQ, Hua SJ, Liewen A, et al. (2014) Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer. Cell 158: 185–197. doi: 10.1016/j.cell.2014.06.003 24954535
50. De Zen L, Sommaggio A, d'Amore ES, Masiero L, di Montezemolo LC, et al. (1997) Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88. Journal of Clinical Oncology 15: 1198–1205. 9060564
51. Whang-Peng J, Knutsen T, Theil K, Horowitz ME, Triche T, (1992) Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosomes Cancer 5: 299–310. 1283318
52. Ganem NJ, Storchova Z, Pellman D, (2007) Tetraploidy, aneuploidy and cancer. Current Opinion in Genetics & Development 17: 157–162.
53. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, et al. (1996) 17P (p53) allelic losses, 4N (G(2)/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Gastroenterology 110: A515–A515.
54. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, et al. (2005) Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437: 1043–1047. 16222300
55. Nishijo K, Chen QR, Zhang L, McCleish AT, Rodriguez A, et al. (2009) Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma. Cancer Research 69: 2902–2911. doi: 10.1158/0008-5472.CAN-08-3723 19339268
56. Naini S, Etheridge KT, Adam SJ, Qualman SJ, Bentley RC, et al. (2008) Defining the Cooperative Genetic Changes That Temporally Drive Alveolar RhabdomyosarcomaU. Cancer Research 68: 9583–9588. doi: 10.1158/0008-5472.CAN-07-6178 19047133
57. Pappo AS, Anderson JR, Crist WM, Wharam MD, Breitfeld PP, et al. (1999) Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study group. Journal of Clinical Oncology 17: 3487–3493. 10550146
58. Trapnell C, Pachter L, Salzberg SL, (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105–1111. doi: 10.1093/bioinformatics/btp120 19289445
59. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, et al. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28: 511–515. doi: 10.1038/nbt.1621 20436464
60. Lam HY, Clark MJ, Chen R, Natsoulis G, O'Huallachain M, et al. (2012) Performance comparison of whole-genome sequencing platforms. Nat Biotechnol 30: 78–82. doi: 10.1038/nbt.2065 22178993
61. Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, et al. (2012) Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483: 589–593. doi: 10.1038/nature10910 22367537
62. Wei X, Walia V, Lin JC, Teer JK, Prickett TD, et al. (2011) Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nature Genetics 43: 442–446. doi: 10.1038/ng.810 21499247
63. Turajlic S, Furney SJ, Lambros MB, Mitsopoulos C, Kozarewa I, et al. (2012) Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res 22: 196–207. doi: 10.1101/gr.125591.111 22183965